Fractionated stereotactic radiotherapy for acoustic neuromas

Jeffery A. Williams, Daniele Rigamonti

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Fractionated stereotactic radiotherapy (FSR) for acoustic neuromas offers both higher tumor dose and potential sparing of the facial and auditory cranial nerve functions. Eighty consecutive patients (45 males and 35 females; age 56.8 ± 1.7 years) received FSR for acoustic neuromas and had a median follow-up of 2.9 years (range 2.3-6.5 years). For FSR, 70 patients had 5 daily fractions of 5 Gy (25 Gy total) and 10 patients had 10 daily fractions of 3 Gy (30 Gy total). Volume decreased by an average of 18%. No tumor increased in size, no patient developed facial weakness, and hearing was preserved. Copyright

Original languageEnglish (US)
Pages (from-to)17-28
Number of pages12
JournalStereotactic and Functional Neurosurgery
Issue number1
StatePublished - Dec 1 2002


  • Acoustic neuroma
  • Fractionation
  • Hearing preservation
  • Radiosurgery
  • Radiotherapy

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'Fractionated stereotactic radiotherapy for acoustic neuromas'. Together they form a unique fingerprint.

Cite this